Article info
PDFTherapeutics
Randomised controlled trial
The 23-valent polysaccharide vaccine prevents pneumococcal pneumonia and reduces associated mortality in nursing home residents in Japan
- Correspondence to Mark Loeb
Michael G DeGroote Centre for Learning, Room 3203, 1200 Main Street, West Hamilton, Ontario, L8N 3Z5, Canada; loebm{at}mcmaster.ca
Citation
The 23-valent polysaccharide vaccine prevents pneumococcal pneumonia and reduces associated mortality in nursing home residents in Japan
Publication history
- First published June 8, 2010.
Online issue publication
October 25, 2017
Article Versions
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions